13153 related articles for article (PubMed ID: 10465586)
1. Effects of transpupillary thermotherapy on immunological parameters and apoptosis in a case of primary uveal melanoma.
Schurmans LR; Blom DJ; De Waard-Siebinga I; Keunen JE; Prause JU; Jager MJ
Melanoma Res; 1999 Jun; 9(3):297-302. PubMed ID: 10465586
[TBL] [Abstract][Full Text] [Related]
2. Histopathological findings in human choroidal melanomas after transpupillary thermotherapy.
Journée-de Korver JG; Oosterhuis JA; de Wolff-Rouendaal D; Kemme H
Br J Ophthalmol; 1997 Mar; 81(3):234-9. PubMed ID: 9135389
[TBL] [Abstract][Full Text] [Related]
3. Additional cell damage after transpupillary thermotherapy in choroidal malignant melanoma.
Kociecki J; Biczysko W; Korver HG; Keunen JE; Pecold K
Melanoma Res; 2001 Oct; 11(5):511-5. PubMed ID: 11595889
[TBL] [Abstract][Full Text] [Related]
4. Transpupillary thermotherapy (TTT) by infrared irradiation of choroidal melanoma.
Journée-de Korver JG; Oosterhuis JA; Kakebeeke-Kemme HM; de Wolff-Rouendaal D
Doc Ophthalmol; 1992; 82(3):185-91. PubMed ID: 1303853
[TBL] [Abstract][Full Text] [Related]
5. Clinicopathologic findings in recurrent choroidal melanoma after transpupillary thermotherapy.
Diaz CE; Capone A; Grossniklaus HE
Ophthalmology; 1998 Aug; 105(8):1419-24. PubMed ID: 9709752
[TBL] [Abstract][Full Text] [Related]
6. Thermotherapy in the management of choroidal melanoma.
Journée-de Korver JG; Keunen JE
Prog Retin Eye Res; 2002 May; 21(3):303-17. PubMed ID: 12052386
[TBL] [Abstract][Full Text] [Related]
7. Expression of Fas and Fas ligand in uveal melanoma: biological implication and prognostic value.
Anastassiou G; Coupland SE; Stang A; Boeloeni R; Schilling H; Bornfeld N
J Pathol; 2001 Aug; 194(4):466-72. PubMed ID: 11523055
[TBL] [Abstract][Full Text] [Related]
8. Depsipeptide (FR901228) inhibits proliferation and induces apoptosis in primary and metastatic human uveal melanoma cell lines.
Klisovic DD; Katz SE; Effron D; Klisovic MI; Wickham J; Parthun MR; Guimond M; Marcucci G
Invest Ophthalmol Vis Sci; 2003 Jun; 44(6):2390-8. PubMed ID: 12766035
[TBL] [Abstract][Full Text] [Related]
9. Ruthenium-106 brachytherapy for choroidal melanoma without transpupillary thermotherapy: Similar efficacy with improved visual outcome.
Marinkovic M; Horeweg N; Fiocco M; Peters FP; Sommers LW; Laman MS; Bleeker JC; Ketelaars M; Luyten GP; Creutzberg CL
Eur J Cancer; 2016 Nov; 68():106-113. PubMed ID: 27741435
[TBL] [Abstract][Full Text] [Related]
10. Peripheral subretinal pigment accumulation following transpupillary thermotherapy for choroidal melanoma.
Kiratli H; Bilgiç S; Söylemezoglu F; Alaçal S
Ophthalmic Surg Lasers Imaging; 2008; 39(1):60-2. PubMed ID: 18254354
[TBL] [Abstract][Full Text] [Related]
11. Primary transpupillary thermotherapy for choroidal melanoma in 391 cases: importance of risk factors in tumor control.
Mashayekhi A; Shields CL; Rishi P; Atalay HT; Pellegrini M; McLaughlin JP; Patrick KA; Morton SJ; Remmer MH; Parendo A; Schlitt MA; Shields JA
Ophthalmology; 2015 Mar; 122(3):600-9. PubMed ID: 25439431
[TBL] [Abstract][Full Text] [Related]
12. Combined plaque radiotherapy and transpupillary thermotherapy in choroidal melanoma: 5 years' experience.
Bartlema YM; Oosterhuis JA; Journée-De Korver JG; Tjho-Heslinga RE; Keunen JE
Br J Ophthalmol; 2003 Nov; 87(11):1370-3. PubMed ID: 14609837
[TBL] [Abstract][Full Text] [Related]
13. Membrane-bound regulators of complement activation in uveal melanomas. CD46, CD55, and CD59 in uveal melanomas.
Goslings WR; Blom DJ; de Waard-Siebinga I; van Beelen E; Claas FH; Jager MJ; Gorter A
Invest Ophthalmol Vis Sci; 1996 Aug; 37(9):1884-91. PubMed ID: 8759358
[TBL] [Abstract][Full Text] [Related]
14. Clinicopathologic findings in choroidal melanomas after failed transpupillary thermotherapy.
Zaldivar RA; Aaberg TM; Sternberg P; Waldron R; Grossniklaus HE
Am J Ophthalmol; 2003 May; 135(5):657-63. PubMed ID: 12719073
[TBL] [Abstract][Full Text] [Related]
15. Role of fas ligand in uveal melanoma-induced liver damage.
Repp AC; Mayhew ES; Howard K; Alizadeh H; Niederkorn JY
Graefes Arch Clin Exp Ophthalmol; 2001 Oct; 239(10):752-8. PubMed ID: 11760036
[TBL] [Abstract][Full Text] [Related]
16. Extended follow-up of small melanocytic choroidal tumors treated with transpupillary thermotherapy.
Win PH; Robertson DM; Buettner H; McCannel CA; Bennett SR
Arch Ophthalmol; 2006 Apr; 124(4):503-6. PubMed ID: 16606875
[TBL] [Abstract][Full Text] [Related]
17. HLA expression in a primary uveal melanoma, its cell line, and four of its metastases.
Blom DJ; Schurmans LR; De Waard-Siebinga I; De Wolff-Rouendaal D; Keunen JE; Jager MJ
Br J Ophthalmol; 1997 Nov; 81(11):989-93. PubMed ID: 9505825
[TBL] [Abstract][Full Text] [Related]
18. HLA expression and tumor-infiltrating immune cells in uveal melanoma.
de Waard-Siebinga I; Hilders CG; Hansen BE; van Delft JL; Jager MJ
Graefes Arch Clin Exp Ophthalmol; 1996 Jan; 234(1):34-42. PubMed ID: 8750848
[TBL] [Abstract][Full Text] [Related]
19. Retinal break and rhegmatogenous retinal detachment after transpupillary thermotherapy as primary or adjunct treatment of choroidal melanoma.
Mashayekhi A; Shields CL; Lee SC; Marr BP; Shields JA
Retina; 2008 Feb; 28(2):274-81. PubMed ID: 18301033
[TBL] [Abstract][Full Text] [Related]
20. Effect of hyperthermia on expression of histocompatibility antigens and heat-shock protein molecules on three human ocular melanoma cell lines.
Blom DJ; De Waard-Siebinga I; Apte RS; Luyten GP; Niederkorn JY; Jager MJ
Melanoma Res; 1997 Apr; 7(2):103-9. PubMed ID: 9167175
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
